Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Molecular Modulators of Adipogenesis as Treatment Options for Obesity

Version 1 : Received: 24 June 2021 / Approved: 25 June 2021 / Online: 25 June 2021 (12:09:51 CEST)

How to cite: Goshu, B.T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints 2021, 2021060620 (doi: 10.20944/preprints202106.0620.v1). Goshu, B.T. Molecular Modulators of Adipogenesis as Treatment Options for Obesity. Preprints 2021, 2021060620 (doi: 10.20944/preprints202106.0620.v1).

Abstract

Abstract: As a risk factor, obesity is a threat to human well-being and related metabolic disorders such as diabetes mellitus and dyslipidemia. adipogenesis is defined as the proliferation and maturation of adipocyte predecessor cells to adipocyte. As the adipogenesis process decides adipocyte production, it may be considered a therapeutic target for obesity and obesity-related disorders. White adipose tissue abnormal expansion increases the size and number of adipocytes. For that reason, this review aims to spot the molecular mechanisms implicated in adipogenesis that lead to application in the therapeutic targets. Keywords: adipogenesis, signaling pathways, anti-obesity treatment, obesity

Keywords

adipogenesis; signaling pathways; anti-obesity treatment; obesity

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.